7.65 (0.47%) Sun Pharmaceutical Industries is looking to raise the share of complex generics and speciality products to its overall business portfolio going forward. This should help the company to drive a stable and consistent growth in cash flows, which is a key objective of its corporate philosophy.
Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.